A phase II trial of high dose cytarabine and fludarabine without anthracycline for patients with core binding factor acute myeloid leukaemia, measuring efficacy, safety and monitoring minimal residual disease.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Fludarabine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 16 Aug 2017 Status changed from active, no longer recruiting to completed.
- 23 Jun 2011 New trial record